| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | CGY4I8F278 |
| Property Name | Value |
|---|---|
| Molecular Formula | C26H28F3N3O4 |
| Molecular Weight | 503.52 |
| AlogP | 5.63 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 10.0 |
| Polar Surface Area | 93.45 |
| Molecular species | None |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 36.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Glucagon receptor antagonist |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetes Mellitus, Type 2 | 2 | D003924 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1393124-08-7 |
| ChEMBL | CHEMBL3544946 |
| FDA SRS | CGY4I8F278 |
| PubChem | 60151939 |